Non-Cisplatin Concurrent Systemic Therapy with Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Network Meta-Analysis of Randomized Clinical Trials.

Cancers (Basel) · 2026 · PMC13204043 · PMID 42192958

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Panitumumab (OR = 864.77; 95%-CI: 191.84–3898.23) was the least favorable treatment regimen and was associated with a highly significant increase in the risk of acneiform rash.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.